Accelerating Biomanufacturing by Modeling of Continuous Bioprocessing—Piloting Case Study of Monoclonal Antibody Manufacturing
An experimental feasibility study on continuous bioprocessing in pilot-scale of 1 L/day cell supernatant, that is, about 150 g/year product (monoclonal antibody) based on CHO (Chinese hamster ovary) cells for model validation is performed for about six weeks including preparation, start-up, batch, a...
Main Authors: | Martin Kornecki, Axel Schmidt, Lara Lohmann, Maximilian Huter, Fabian Mestmäcker, Leon Klepzig, Mourad Mouellef, Steffen Zobel-Roos, Jochen Strube |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Processes |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9717/7/8/495 |
Similar Items
-
Model Validation and Process Design of Continuous Single Pass Tangential Flow Filtration Focusing on Continuous Bioprocessing for High Protein Concentrations
by: Maximilian Johannes Huter, et al.
Published: (2019-11-01) -
Towards Autonomous Operation by Advanced Process Control—Process Analytical Technology for Continuous Biologics Antibody Manufacturing
by: Heribert Helgers, et al.
Published: (2021-01-01) -
Brief Note on the Development of Biotechnology
by: Karl Bayer
Published: (2014-01-01) -
PAT for Continuous Chromatography Integrated into Continuous Manufacturing of Biologics towards Autonomous Operation
by: Florian Lukas Vetter, et al.
Published: (2021-03-01) -
Implementation of QbD strategies in the inoculum expansion of a mAb production process
by: Ole Jacob Böhl, et al.
Published: (2021-03-01)